factorial designs
FORMULATION AND OPTIMIZATION OF MUCOADHESIVE BUCCAL TABLETS OF NIFEDIPINE USING 23 FULL FACTORIAL DESIGNS
... The objective of this current investigation is to highlights the novel sustained release mucoadhesive buccal tablets containing nifedipine by using various proportions of mucoadhesive polymers such as xanthan gum, ...
8
A useful empirical Bayesian method to analyse industrial data from saturated factorial designs Pages 337-344 Download PDF
... of factorial designs in industrial ...employed factorial designs to investigate the surface roughness when orthogonal cutting tests were carried on unidirectional glass fibre reinforced ...
8
The Effects Of Drugs On Mice Of Three Strains Using 32 Factorial Designs
... factorial designs. The analysis of the RBC shows that there is no interaction effect between the strains of mice and the three dose level. The three strains of mice and dose level are found not to be ...
8
OPTIMIZATION OF IRBESARTAN TABLET FORMULATION EMPLOYING ?CD AND CROSPOVIDONE BY 22 FACTORIAL DESIGNS
... www.wjpr.net Vol 3, Issue 9, 2014. 944 tablet formulation with NLT 85% dissolution in 15 min employing Crospovidone and βCD by 2 2 factorial design. Optimization [6] of pharmaceutical formulations involves ...
9
FORMULATION DEVELOPMENT OF IRBESARTAN TABLETS: SELECTION OF DILUENT- BINDER-DISINTEGRANT COMBINATION BY 23 FACTORIAL DESIGNS
... 3 factorial designs for selecting the best combinations of diluent, binder and disintegrant giving fast dissolution of the ...3 factorial design the three factors involved are binder, diluent and ...
6
Fitting Second-order Models to Mixed Two-level and Four-level Factorial Designs: Is There an Easier Procedure?
... reviewed factorial design application in works published from 1965 to 1972 and found that most of the studies utilized fractional factorial ...two-level designs and fitting a first-order response ...
7
Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods
... in factorial designs was assessed by simulating a balanced 2 × 2 factorial design with a sample size of 128, chosen so that there was 80 % power to detect a treatment effect of specified size in one ...
13
Automatic generation of generalised regular factorial designs
... non-regular factorial designs are ...incomplete-block designs where the block size does not divide the number of treatments, and orthogonal arrays, such as those obtained from Hadamard matrices ...
19
Characterization of Six Categories of Systematic 2n－(n－k) Fractional Factorial Designs
... fractional factorial designs for carrying out fractional fac- torial experiments randomly or ...fractional factorial designs that can be carried out systematically run after run in minimum ...
14
FORMULATION AND IN VITRO EVALUATION OF METRONIDAZOLE LOADED HPMC K15M MUCOADHESIVE MICROCAPSULES FOR H PYLORI INFECTION USING 32 FULL FACTORIAL DESIGNS
... 2 factorial designs. A 3 2 full factorial designs were used to derive a statistical equation, ANOVA analysis, contour plots, and 3D response surface ...
13
Rank Order Outlier (ROO) plots to detect possible outliers in unreplicated 2k completely randomized factorial designs: Numerical example
... Analyzing data from unreplicated factorial experiment is not simple. It dues to the fact that when there is no replications, the residual error equals to zero and calculation of the F statistics is not possible. ...
5
Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems – enhancement of oral bioavailability
... Custom fractional factorial design was utilized to optimize the clear region area of SNEDDS components ternary phase and NS formulations parameters. The development of opti- mized ATR SNEDDS and NS formulae can ...
12
A statistical study on the development of metronidazole-alginate-chitosan nanocomposite formulations using Full factorial designs
... Experimental designs (ED) is a method where the independent variables are initially screened to establish and they are more effective to the product ...mixture designs; it contains changing mixture content ...
33
Formulation and evaluation of gastroretentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs)
... The word ‘optimize’ is defined as, to make as perfect, effective or functional as possible and optimization may be interpreted as the way to find those values of the dependent variable. The application of formulation ...
44
DESIGN AND CHARACTERIZATION OF PH-TRIGERED INSITU GEL CONTAINING GATIFLOXACIN AND DEXOMETHASONE BY 32 FACTORIAL DESIGNS
... 934P/gellan gum are used to increase the viscosity of formulation in order to prolong the pre-corneal residence time & improve the bioavailability, ease to manufacture. Penetration enhancer: preservatives, chelating ...
15
DESIGN AND CHARACTERIZATION OF ETHYL CELLULOSE-BASED COLON SPECIFIC MICROSPHERE CONTAINING NAPROXEN USING 32 FACTORIAL DESIGNS
... factor three-level full factorial design was used for systemic study of combination of polymers. Polynomial models including interaction and quadratic terms were generated for the entire response variables using ...
14
Optimization of EDM Parameters for Minimum Surface Roughness during Electric Discharge Machining using Two Level Full Factorial Designs
... During electric discharge machining the main output parameters are the material removal rate (MRR), tool wear and surface finish. To increase the productivity, it is desirable to obtain the maximum MRR with minimum ...
8
Factorial Designs Application to Study Enhanced Bioremediation of Soil Artificially Contaminated with Weathered Bonny Light Crude Oil through Biostimulation and Bioaugmentation Strategy
... experiment designs most widely used in opti- mization experiments are termed response surface de- signs ...These designs provide information about direct effects, pair wise interaction effects and cur- ...
12
FORMULATION AND EVALUATION OF TIZANIDINE HYDROCHLORIDE MICROSPHERES BY USING 32 FULL FACTORIAL DESIGNS
... hydrochloride is its low bioavailability (30 to 40%), short biological half life (4.2 h) and the fact that it undergoes first pass metabolism. Thus the development of controlled release dosage forms would clearly be ...
6